Adverse events triggering a dose adjustment included general gastrointestinal signs (lack of appetite, diarrhea), weight loss, grade I neutropenia, grade I azotemia, and grade II elevations in liver enzymes (alkaline phosphatase and alanine aminotransferase). Here, GPT is linked to Decreased total neutrophil count.